Therapeutic adherence in vulnerable chronic patients using personalised dosage systems in community pharmacy in Región de Murcia
DOI:
https://doi.org/10.60103/phc.v28.e944Keywords:
Medication adherence, Chronic disease, Pharmaceutical Care Professional Services, Medication dosing systems, Vulnerable populationsAbstract
Objective: To evaluate the implementation and outcomes of a medication adherence programme based on the provision of Pharmaceutical Care Services to vulnerable patients with chronic conditions in the municipalities of Cartagena and San Javier (Region of Murcia, Spain).
Methods: A descriptive observational study conducted in community pharmacies trained in Pharmaceutical Care Services and registered with Nodofarma Asistencial. Patients with chronic conditions experiencing economic and/or social vulnerability, referred by healthcare and social services and meeting predefined economic and health-related criteria, were included. The intervention combined a Medication Adherence Service (patient interview, medication review, adherence assessment and quality-of-life assessment using the EuroQol EQ-5D-5L and visual analogue scale) with weekly medication repackaging into Personalised Medication Dosage Systems (PMDS), with monthly follow-up at the pharmacy. The Red Cross provided social support through fortnightly telephone calls and home visits, while the municipal councils funded the project.
Results: A total of 67 patients were included during the study period, with 669 visits recorded in Nodofarma Asistencial as part of the Medication Adherence Service. The proportion of patients classified as adherent at the end of follow-up was 69.05%, and the mean quality-of-life score increased by 12.2%. A total of 25 drug-related problems (DRPs) were identified, of which 69.5% were resolved, with drug interactions being the most frequent. These resulted in 25 potential negative medication-related outcomes (NMOs), the most frequent being non-quantitative medication safety problems. A total of 2,206 remunerated PMDS units were prepared, at a reimbursement rate of €36.52 per patient per month. Arterial hypertension was the most prevalent condition, and forgetfulness was the main cause of non-adherence.
Conclusions: The combination of a structured medication adherence service and personalised medication dosage systems delivered through community pharmacies, in coordination with social services, improves medication adherence and perceived health status among vulnerable patients with chronic conditions and facilitates the identification and resolution of relevant pharmacotherapeutic and social problems.
Downloads
References
Ministerio de Sanidad. Principales problemas crónicos de salud, porcentaje de población de 15 y más años que padece determinados problemas crónicos, registrado en atención primaria, por comunidad autónoma. Año 2024 [Internet]. Madrid: Ministerio de Sanidad. Disponible en: https://www.sanidad.gob.es/estadEstudios/sanidadDatos/tablas/tabla5.htm
Eurostat. Self-perceived health statistics. Statistics Explained [Internet]. Luxemburgo: Comisión Europea; 2026. Datos correspondientes a 2024. Disponible en: https://ec.europa.eu/eurostat/statistics-explained/index.php/Self-perceived_health_statistics
Instituto Nacional de Estadística. Personas con enfermedades o problemas de salud de larga duración por comunidad autónoma. Indicadores de Calidad de Vida [Internet]. Madrid: INE; actualización 31 oct 2025. Disponible en: https://www.ine.es/jaxiT3/Tabla.htm?t=69640
Foley L, Larkin J, Lombard-Vance R, Murphy AW, Hynes L, Galvin E, et al. Prevalence and predictors of medication non-adherence among people living with multimorbidity: a systematic review and meta-analysis. BMJ Open. 2021;11(9):e044987.
World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003. Disponible en: https://iris.who.int/items/bf8058c0-03b2-4b47-838f-5534849927fb
Parekh N, Ali K, Stevenson JM, Davies JG, Schiff R, Van der Cammen TJM, et al. Incidence and cost of medication harm in older adults following hospital discharge: a multicentre prospective study in the UK. Br J Clin Pharmacol. 2018;84(8):1789-1797. https://doi.org/10.1111/bcp.13613
Álvarez Payero M, Martínez López de Castro N, Ucha Samartín M, Martín Vila A, Vázquez López C, Piñeiro Corrales G. Medication non-adherence as a cause of hospital admissions. Farm Hosp. 2014;38(4):328-333.
Valdés y Llorca C, Barajas-Nava LA, García-Cárdenas V, Varas-Doval R, Gastelurrutia-Garralda MA, Faus MJ, et al. Factors associated with non-adherence to drugs in patients with chronic diseases who go to pharmacies in Spain. Int J Environ Res Public Health. 2021;18(8):4308. https://doi.org/10.3390/ijerph18084308
Chauke GD, Nakwafila O, Chibi B, Sartorius B, Mashamba-Thompson T. Factors influencing poor medication adherence amongst patients with chronic disease in low-and-middle-income countries: a systematic scoping review. Heliyon. 2022;8(6):e09716. doi: 10.1016/j.heliyon.2022.e09716
Lu J, Zhang N, Mao D, Wang Y, Wang X. How social isolation and loneliness effect medication adherence among elderly with chronic diseases: an integrated theory and validated cross-sectional study. Arch Gerontol Geriatr. 2020;90:104154.
Torres-Novellas B, Llauradó L, Sabaté M, Pérez E, Capellà D, Amariles P, et al. Drug-related problems detected in complex chronic patients by community pharmacists of Catalonia: perception of the person-centred approach necessity. Healthcare (Basel). 2024;12(2):240.
Torres-Robles A, Wiecek E, Tonin FS, Benrimoj SI, Fernández-Llimós F, García-Cárdenas V. Effectiveness of a medication adherence management intervention in a community pharmacy setting: a cluster randomised controlled trial. BMJ Qual Saf. 2022;31(2):105-115.
Moges TA, Dagnew SB, Wondm SA, Ferede YA, Yiblet TG, Almaw A, et al. Determinants of medication non-adherence among patients with chronic diseases at community pharmacy settings in South Gondar Zone, Northwest Ethiopia: a multicenter cross-sectional study. Front Public Health. 2024;12:1409153. https://doi.org/10.3389/fpubh.2024.1409153
Huang J, Wang HHX, Zheng Z, Wong MCS. Medication adherence among the older adults: challenges and recommendations. Hong Kong Med J. 2020;26(6):476-478.
Schulz RM, Porter C, Lane M, Cornman C, Branham L. Impact of a medication management system on nursing home admission rate in a community-dwelling nursing home-eligible Medicaid population. Am J Geriatr Pharmacother. 2011 Feb;9(1):69-79. doi: 10.1016/j.amjopharm.2011.02.008.
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67-74.
Herdman M, Gudex C, Lloyd A, Janssen MF, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727-1736.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 María Jesús Rodríguez Arcas, José Juan González García-Arquimbau, África García Jiménez, María José Cecilia Reche, Beatriz Jurado Obis, Ana Belén Martínez Aguado

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
La revista Pharmaceutical Care España se publica bajo una licencia «Creative Commons, Reconocimiento, No Comercial y Compartir Igual 4.0 Internacional» (CC BY-NC-SA 4.0)», que permite a otros compartir el trabajo con un reconocimiento de la autoría del trabajo y la publicación inicial en esta revista (con excepción de los usos comerciales).
Los autores que publican en esta revista están de acuerdo con los siguientes términos:a) Los autores conservan los derechos de autor (derechos morales) y garantizan a la revista el derecho de ser el primer soporte documental publicado del trabajo.
b) Se permite y anima a los autores a difundir la versión del trabajo revisado por pares y aceptada para su publicación (por ejemplo, en repositorios institucionales o temáticos), recomendando hacerlo con la versión final del editor “pdf”, “html” o “xml”).



